An Array of New Drugs Show Promise in Fighting Addiction by: Gautam Naik The Wall Street Journal — (July 15, 2002) Could people be inoculated against drug addictions the way they can against some infectious diseases? It may be possible. Despite disappointing past efforts to treat addictions with medicine, recent…
by Jerome Burne Focus Magazine / (July 2000) Beneath a brilliant vault of stars, a young man is sitting on a rug somewhere out in the South African veldt. But he only has eyes for the extraordinary parade of images inside his head. There is a tremor to his legs…
by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others,…
ADDICTION RESEARCH: Ibogaine Therapy: A ‘Vast, Uncontrolled Experiment’ by Brian Vastag (Science, Vol 308, Issue 5720, 345-346 , 15 April 2005) Despite potentially harsh side effects, an African plant extract is being tested in two public clinical trials — and many clandestine ones On a snowy President’s Day, an odd…
Human Pharmacology of Oral DMT Plus Harmine Copyright © 1997, Jonathan Ott All Rights Reserved / Reproduced by Permission of Jonathan Ott (Original Publication: Yearbook for Ethnomedicine 1997/98) Abstract A summary is presented of human self-experiments or psychonautic bioassays of pharmahuasca-capsules containing crystalline N,N-dimethyltryptamine (DMT) plus harmine, as well as…
Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of…
Reprinted from Neurobiological Mechanisms of Drugs of Abuse Volume 914 of the Annals of the New York Academy of Sciences September 2000 Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures DEBORAH C. MASH,[a,b,h] CRAIG A. KOVERA,[o] JOHN PABLO,[o] RACHEL F. TYNDALE,[c] FRANK D. ERVIN,[d] IZBEN C. WILLIAMS,[e] EDWARD…
Copyright © 1995, Paul De Rienzo, Dana Beal and Members of the Project All Rights Reserved CHAPTER 18: Deborah Mash’s Brain In March, 1994, in strictest secrecy, Howard Lotsof re-instituted treatments of addict volunteers in an ultramodern hospital in Panama City, with pre-treatment work-ups at the University of Miami. But…
Copyright © 1995-1996, Paul De Rienzo, Dana Beal and Members of the Project All Rights Reserved CHAPTER 17: Cures Not Wars In February, 1994, Robert Rygor died. He’d become a beneficiary of the free pot program, and as facilitator of ACT UP Coordinating Committee, which set the agenda for the…
Copyright © 1995-1996, Paul De Rienzo, Dana Beal and Members of the Project All Rights Reserved CHAPTER 15: Molliver’s Travels Behind the scenes, as is often the case, the postponement of the Day One Ibogaine story was being dictated by other agendas and other schedules. In April, unbeknownst to Lotsof…